Results 151 to 160 of about 3,838,438 (312)
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Reducing the burden of osteoarthritis in Australia: A 2024-2025 research priority-setting study. [PDF]
Bennell KL +11 more
europepmc +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
170:poster Priority setting across different levels of decision-making: the way forward
Carl Tollef Solberg, Sindre A Horn
doaj +1 more source
Patient-Oriented Priorities for Pediatric Erythromelalgia: A Priority-Setting Process. [PDF]
Ocay DD +25 more
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Global childhood cancer survival estimates and priority-setting: a simulation-based analysis.
Zachary J. Ward +6 more
semanticscholar +1 more source
Priority setting for supportive care research in children and young people with cancer. [PDF]
Morgan JE, Evans C, Phillips RS.
europepmc +1 more source

